Importantly, mechanistic studies in a T cell receptor transgenic (TCR Tg) CD8 T cell-induced mouse model of vitiligo, revealed that anti-CD122 mAb treatment repigmented vitiligo-affected skin in a highly durable fashion (119). This evidence concerns the gene IL2RB and vitiligo.